Thursday, 27th January 2022
<To guardian.ng
Search
Breaking News:

Does drinking hot coffee cause cancer?

By Chukwuma Muanya, Assistant Editor (Head Insight Team, Science & Technology)
23 June 2016   |   4:10 am
A summary of the final evaluations was published yesterday in The Lancet Oncology, and the detailed assessments would be published as Volume 116 of the IARC Monographs.
 After thoroughly reviewing more than 1000 studies in humans and animals, the WHO Working Group found that there was inadequate evidence for the carcinogenicity of coffee drinking overall. Many epidemiological studies showed that coffee drinking had no carcinogenic effects for cancers of the pancreas, female breast, and prostate, and reduced risks were seen for cancers of the liver and uterine endometrium. For more than 20 other cancers, the evidence was inconclusive.

After thoroughly reviewing more than 1000 studies in humans and animals, the WHO Working Group found that there was inadequate evidence for the carcinogenicity of coffee drinking overall. Many epidemiological studies showed that coffee drinking had no carcinogenic effects for cancers of the pancreas, female breast, and prostate, and reduced risks were seen for cancers of the liver and uterine endometrium. For more than 20 other cancers, the evidence was inconclusive.

• WHO found no conclusive evidence that regular intake causes tumour
• Classified taking very hot beverages as probably carcinogenic to human

The media were awash last week that drinking coffee and very hot beverages causes cancer. But the World Health Organisation (WHO) in a swift reaction said its Working Group found no conclusive evidence for a carcinogenic effect of drinking coffee.

An international Working Group of 23 scientists convened by the International Agency for Research on Cancer (IARC), the cancer agency of the WHO, has evaluated the carcinogenicity of drinking coffee, maté, and very hot beverages.

A summary of the final evaluations was published yesterday in The Lancet Oncology, and the detailed assessments would be published as Volume 116 of the IARC Monographs.

The experts, however, did find that drinking very hot beverages probably causes cancer of the oesophagus in humans. No conclusive evidence was found for drinking mate at temperatures that are not very hot.

IARC Director, Dr. Christopher Wild, said: “These results suggest that drinking very hot beverages is one probable cause of oesophageal cancer and that it is the temperature, rather than the drinks themselves, that appears to be responsible.”

Drinking very hot beverages was classified as probably carcinogenic to humans (Group 2A). This was based on limited evidence from epidemiological studies that showed positive associations between cancer of the oesophagus and drinking very hot beverages.

Studies in places such as China, the Islamic Republic of Iran, Turkey, and South America, where tea or mate is traditionally drunk very hot (at about 70 °C), found that the risk of oesophageal cancer increased with the temperature at which the beverage was drunk.

In experiments involving animals, there was also limited evidence for the carcinogenicity of very hot water. “Smoking and alcohol drinking are major causes of oesophageal cancer, particularly in many high-income countries,” stressed Wild. “However, the majority of oesophageal cancers occur in parts of Asia, South America, and East Africa, where regularly drinking very hot beverages is common and where the reasons for the high incidence of this cancer are not as well understood.”

Oesophageal cancer is the eighth most common cause of cancer worldwide and one of the main causes of cancer death, with approximately 400,000 deaths recorded in 2012 (five per cent of all cancer deaths).

The proportion of oesophageal cancer cases that may be linked to drinking very hot beverages is not known.

Cold mate did not have carcinogenic effects in experiments on animals or in epidemiological studies. Therefore, drinking mate at temperatures that are not very hot was not classifiable as to its carcinogenicity to humans (Group 3). This was based on inadequate evidence in humans for the carcinogenicity of drinking cold or warm mate and inadequate evidence in experimental animals for the carcinogenicity of cold mate as a drinking liquid.

Maté is an infusion made from dried leaves of Ilex paraguariensis. It is consumed mainly in South America and to a lesser extent in the Middle East, Europe, and North America. Maté is traditionally drunk very hot (at about 70°C), but it may also be consumed warm or cold. “Very hot” refers to any beverages consumed at a temperature above 65 °C.

Drinking coffee was not classifiable as to its carcinogenicity to humans (Group 3). The large body of evidence currently available led to the re-evaluation of the carcinogenicity of coffee drinking, previously classified as possibly carcinogenic to humans (Group 2B) by IARC in 1991.

After thoroughly reviewing more than 1000 studies in humans and animals, the Working Group found that there was inadequate evidence for the carcinogenicity of coffee drinking overall.

Many epidemiological studies showed that coffee drinking had no carcinogenic effects for cancers of the pancreas, female breast, and prostate, and reduced risks were seen for cancers of the liver and uterine endometrium.

For more than 20 other cancers, the evidence was inconclusive.

The IARC Monographs Programme seeks to classify cancer hazards, meaning the potential of any substance to cause cancer based on current knowledge.
The classification does not indicate what level of risk exists to people’s health associated with exposure to a classified hazard.

For example, IARC has classified tobacco smoking as carcinogenic to humans (Group 1). But that classification does not indicate the increase in risk for each cigarette smoked.

The is Working Group evaluation is in line with the WHO Technical Report Series 916 on Diet, Nutrition and the Prevention of Chronic Diseases, which states that people should not consume drinks when they are at a very hot (scalding hot) temperature.

The IARC is part of WHO. Its mission is to coordinate and conduct research on the causes of human cancer and the mechanisms of carcinogenesis, and to develop scientific strategies for cancer control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.